Tenecteplase can be given to patients with intermediate-risk pulmonary embolism--but should it?

Thromb Res. 2010 Dec;126(6):e407-8. doi: 10.1016/j.thromres.2009.10.010. Epub 2009 Nov 6.
No abstract available

Publication types

  • Editorial
  • Kommentar

MeSH terms

  • Fibrinolytic Agents / administration & dosage*
  • Humans
  • Pulmonary Embolism / drug therapy*
  • Pulmonary Embolism / physiopathology
  • Risk Factors
  • Tenecteplase
  • Tissue Plasminogen Activator / administration & dosage*

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator
  • Tenecteplase